OtsukaLtd. 

M$1,025.98
78
+M$0+0% Thursday 14:53

Statistics

Day High
1,025.98
Day Low
1,025.98
52W High
1,247.81
52W Low
840.71
Volume
0
Avg. Volume
3,445
Mkt Cap
557.1B
P/E Ratio
-
Dividend Yield
0.74%
Dividend
7.63

Upcoming

Dividends

0.74%Dividend Yield
Mar 26
M$8.04
Sep 25
M$9.12
Mar 25
M$7.96
Sep 24
M$6.83
Mar 24
M$7.19
10Y Growth
-1.34%
5Y Growth
-2.49%
3Y Growth
6.41%
1Y Growth
-8.05%

Earnings

28AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
8.18
17.52
26.86
36.2
Expected EPS
14.897672756933437
Actual EPS
N/A

Financials

14.85%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
602.51BRevenue
89.49BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4578N.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a global pharmaceutical company that competes with Otsuka in various therapeutic areas, including psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson, through its pharmaceutical segment, competes directly with Otsuka in the development and marketing of drugs for various conditions.
Novartis
NVS
Mkt Cap293.34B
Novartis is a leading healthcare company that competes with Otsuka in several areas, including neuroscience and digital health solutions.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline competes with Otsuka in the pharmaceutical sector, particularly in the development of medications for psychiatric conditions.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie competes with Otsuka in the neuroscience domain, particularly in the development of treatments for psychiatric disorders.
Merck
MRK
Mkt Cap294.39B
Merck & Co. competes with Otsuka in the healthcare sector, focusing on pharmaceuticals that address critical areas of health.
Takeda Pharmaceutical
TAK
Mkt Cap56.3B
Takeda Pharmaceutical Company competes with Otsuka, especially in Japan and in the field of neuroscience, sharing a similar market focus.
Rogers
ROG
Mkt Cap2.18B
Roche Holding AG competes with Otsuka in the pharmaceutical and diagnostics sectors, particularly in areas like personalized healthcare.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca competes with Otsuka in various therapeutic areas, including the development of treatments for diseases in oncology and cardiovascular.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb competes with Otsuka in the pharmaceutical sector, particularly in the development of innovative medicines for serious diseases.

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Show more...
CEO
ISIN
JP3188220002

Listings

0 Comments

Share your thoughts

FAQ

What is OtsukaLtd. stock price today?
The current price of 4578N.MX is M$1,025.98 MXN — it has increased by +0% in the past 24 hours. Watch OtsukaLtd. stock price performance more closely on the chart.
What is OtsukaLtd. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange OtsukaLtd. stocks are traded under the ticker 4578N.MX.
What is OtsukaLtd. market cap?
Today OtsukaLtd. has the market capitalization of 557.1B
When is the next OtsukaLtd. earnings date?
OtsukaLtd. is going to release the next earnings report on April 28, 2026.
What were OtsukaLtd. earnings last quarter?
4578N.MX earnings for the last quarter are 13.6 MXN per share, whereas the estimation was 8.18 MXN resulting in a +66.18% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is OtsukaLtd. revenue for the last year?
OtsukaLtd. revenue for the last year amounts to 602.51B MXN.
What is OtsukaLtd. net income for the last year?
4578N.MX net income for the last year is 89.49B MXN.
Does OtsukaLtd. pay dividends?
Yes, 4578N.MX dividends are paid semi-annual. The last dividend per share was 8.04 MXN. As of today, Dividend Yield (FWD)% is 0.74%.
In which sector is OtsukaLtd. located?
OtsukaLtd. operates in the Other sector.
When did OtsukaLtd. complete a stock split?
OtsukaLtd. has not had any recent stock splits.